FINAL DIAGNOSIS:
PART 1: PELVIC TUMOR NODULE, EXCISION —
A. POORLY DIFFERENTIATED CARCINOMA.
B. TUMOR MEASURES UP TO APPROXIMATELY 1 CM IN GREATEST DIMENSION.

 

PART 2: LEFT ADNEXA, SALPINGO-OOPHORECTOMY —

POORLY DIFFERENTIATED PAPILLARY SEROUS ADENOCARCINOMA (see comment).
TUMOR MEASURES 5. 4 CM IN GREATEST DIMENSION.

LYMPHOVASCULAR INVASION IS PRESENT

TUMOR INVOLVES BOTH THE SEROSAL AND LUMINAL ASPECTS OF THE FALLOPIAN TUBE.
RESIDUAL OVARIAN TISSUE IS NOT IDENTIFIED.

mppw?

PART 3: RIGHT ADNEXA, SALPINGO-OOPHORECTOMY --
A. OVARY WITH iNVOLVEMENT BY MULTIPLE NODULES OF POORLY DIFFERENTIATED CARCINOMA
MEASURING UP TO APPROXIMATELY 1.0 CM IN GREATEST DIMENSION.
B. FALLOPIAN TUBE WITH ADHESIONS, NEGATIVE FOR NEOPLASM.

PART 4: PELVIC TUMOR EXCISION —
SEGMENTS 0F FIBROADIPOSE TISSUE WITH POORLY DIFFERENTIATED CARCINOMA MEASURING UP TO
APPROXIMATELY 0.5 CM IN GREATEST DIMENSION.

PART 5: OMENTUM, OMENTECTOMY -—
POORLY DIFFERENTIATED ADENOCARCINOMA, MEASURING APPROXIMATELY 1.5 CM IN GREATEST
DIMENSION. '

PART 6: LEFT PERIAORTIC LYMPI-I NODES, BIOPSY—
A. ONE LYMPH NODE WITH METASTATIC ADENOCARCINOMA (111).
B. METASTASIS MEASURES APPROXIMATELY 2.2 CM IN GREATEST DIMENSION.
C. EXTRACAPSULAR EXTENSION IS PRESENT (APPROXIMATELY 7 MM).

PART 7: LEFT PELVIC LYMPH NODES. BIOPSY—-
A. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0”).
B. MINUTE SUBCAPSULAR FRAGMENT OF ATYPICAL CELLS.

PART 8: INTRAABDOMINAL CLOT, EXCISION -
ORGANIZING HEMORRHAGE.

PART 9: RIGHT PERIAORTIC LYMPH NODES, BIOPSY—
ONE LYMPH NODE, NEGATIVE FOR NEOPLASM (0“).

PART 10: AORTIC CAVAL LYMPH NODE, BIOPSY —
ONE LYMPH NODE, NEGATIVE FOR NEOPLASM (011).

PART 11: APPENDIX AND APPENDICEAL STUMP, APPENDECTOMY —
APPENDIX WITH FIBRINOUS ADHESIONS, NEGATIVE FOR NEOPLASM.

PART 12', BOWEL TUMOR, EXCISION -
SEGMENTS OF POORLY DIFFERENTIATED CARCINOMA MEASURING UP TO PROXIMATELY 0. 6 CM IN
GREATEST DIMENSION.

PART 13: MESENTERIC LYMPH NODE, BIOPSY —
ONE LYMPH NODE, NEGATIVE FOR NEOPLASM (0“).

PART 14: RIGHT UPPER QUADRANT MASS, EXCISION -
A. SMALL FOCI OF POORLY DIFFERENTIATED CARCINOMA MEASURING UP TO APPROXIMATELY 1.5 CM IN
GREATEST DIMENSION.
B. ADHESIONS, FAT NECROSIS, AND GRANULATION TISSUE.

 

